Factors associated with death at 1 year in patients with unresected NSCLC: the CAP-Centre study
| Potential risk factors of death at 1 year – patients with unresected NSCLC (n=360) | Hazard ratio | 95% confidence interval |
| General characteristics | ||
| Age ≥65 years | 1.2 | (0.8–1.6) |
| Male | 1.0 | (0.7–1.5) |
| PS >1 | 2.1 | (1.5–3.0) |
| Histology | ||
| Adenocarcinoma | ref | |
| Squamous cell carcinoma | 1.6 | (1.1–2.4) |
| Undifferentiated carcinoma | 2.0 | (1.3–3.1) |
| Others | 1.4 | (0.6–2.9) |
| Metastatic stage | 2.4 | (1.6–3.8) |
| Healthcare pathway | ||
| No immunotherapy | 1.8 | (1.3–2.7) |
| No targeted therapy | 2.5 | (1.3–4.9) |
| No radiotherapy | 2.8 | (1.7–4.7) |
| Administrative department of the first healthcare facility | ||
| A | 1.1 | (0.5–2.3) |
| B | 1.9 | (1.1–3.3) |
| C | 0.8 | (0.4–2.0) |
| D | ref | |
| E | 1.3 | (0.6–2.5) |
| F | 0.8 | (0.6–1.3) |
| Outside of the CVL region | 1.7 | (0.7–3.8) |
| Nature of the first healthcare facility | ||
| Teaching hospital | ref | |
| Public hospital | 0.8 | (0.5–1.3) |
| Private hospital | 0.5 | (0.4–0.8) |
| Time interval between diagnostic imaging and first treatment <49 days# | 1.5 | (1.1–2.1) |
NSCLC: nonsmall cell lung cancer; PS: performance status; CVL: Centre-Val de Loire. #: 49 days corresponded to the median time interval between diagnostic imaging and first treatment.